|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date25 Aug 2021 |
100 Clinical Results associated with VISEN Pharmaceuticals
0 Patents (Medical) associated with VISEN Pharmaceuticals
100 Deals associated with VISEN Pharmaceuticals
100 Translational Medicine associated with VISEN Pharmaceuticals